Zymeworks Total Liabilities 2016-2022 | ZYME
Zymeworks total liabilities from 2016 to 2022. Total liabilities can be defined as the total value of all possible claims against the corporation.
Zymeworks Annual Total Liabilities
(Millions of US $) |
| 2021 |
$140 |
| 2020 |
$128 |
| 2019 |
$123 |
| 2018 |
$64 |
| 2017 |
$16 |
| 2016 |
$26 |
| 2015 |
$5 |
Zymeworks Quarterly Total Liabilities
(Millions of US $) |
| 2022-06-30 |
$147 |
| 2022-03-31 |
$148 |
| 2021-12-31 |
$140 |
| 2021-09-30 |
$141 |
| 2021-06-30 |
$150 |
| 2021-03-31 |
$113 |
| 2020-12-31 |
$128 |
| 2020-09-30 |
$139 |
| 2020-06-30 |
$116 |
| 2020-03-31 |
$114 |
| 2019-12-31 |
$123 |
| 2019-09-30 |
$91 |
| 2019-06-30 |
$81 |
| 2019-03-31 |
$68 |
| 2018-12-31 |
$64 |
| 2018-09-30 |
$25 |
| 2018-06-30 |
$25 |
| 2018-03-31 |
$19 |
| 2017-12-31 |
$16 |
| 2017-09-30 |
$17 |
| 2017-06-30 |
$18 |
| 2017-03-31 |
$30 |
| 2016-12-31 |
$26 |
| 2016-09-30 |
$0 |
| 2016-06-30 |
$0 |
| 2016-03-31 |
$0 |
| 2015-12-31 |
$5 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.570B |
$0.412B |
|
Zymeworks Inc. is a clinical-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer in Canada. The companys lead product candidate includes ZW25 and ZW33 which are in clinical trial stage. Zymeworks Inc. is headquartered in Vancouver, Canada.
|
